Literature DB >> 24038936

Clinical significance of de novo and inherited copy-number variation.

Anneke T Vulto-van Silfhout1, Jayne Y Hehir-Kwa, Bregje W M van Bon, Janneke H M Schuurs-Hoeijmakers, Stephen Meader, Claudia J M Hellebrekers, Ilse J M Thoonen, Arjan P M de Brouwer, Han G Brunner, Caleb Webber, Rolph Pfundt, Nicole de Leeuw, Bert B A de Vries.   

Abstract

Copy-number variations (CNVs) are a common cause of intellectual disability and/or multiple congenital anomalies (ID/MCA). However, the clinical interpretation of CNVs remains challenging, especially for inherited CNVs. Well-phenotyped patients (5,531) with ID/MCA were screened for rare CNVs using a 250K single-nucleotide polymorphism array platform in order to improve the understanding of the contribution of CNVs to a patients phenotype. We detected 1,663 rare CNVs in 1,388 patients (25.1%; range 0-5 per patient) of which 437 occurred de novo and 638 were inherited. The detected CNVs were analyzed for various characteristics, gene content, and genotype-phenotype correlations. Patients with severe phenotypes, including organ malformations, had more de novo CNVs (P < 0.001), whereas patient groups with milder phenotypes, such as facial dysmorphisms, were enriched for both de novo and inherited CNVs (P < 0.001), indicating that not only de novo but also inherited CNVs can be associated with a clinically relevant phenotype. Moreover, patients with multiple CNVs presented with a more severe phenotype than patients with a single CNV (P < 0.001), pointing to a combinatorial effect of the additional CNVs. In addition, we identified 20 de novo single-gene CNVs that directly indicate novel genes for ID/MCA, including ZFHX4, ANKH, DLG2, MPP7, CEP89, TRIO, ASTN2, and PIK3C3.
© 2013 WILEY PERIODICALS, INC.

Entities:  

Keywords:  CNV; SNP; copy number variation; genotype-phenotype; human phenotype ontology

Mesh:

Year:  2013        PMID: 24038936     DOI: 10.1002/humu.22442

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  52 in total

1.  The Koolen-de Vries syndrome: a phenotypic comparison of patients with a 17q21.31 microdeletion versus a KANSL1 sequence variant.

Authors:  David A Koolen; Rolph Pfundt; Katrin Linda; Gea Beunders; Hermine E Veenstra-Knol; Jessie H Conta; Ana Maria Fortuna; Gabriele Gillessen-Kaesbach; Sarah Dugan; Sara Halbach; Omar A Abdul-Rahman; Heather M Winesett; Wendy K Chung; Marguerite Dalton; Petia S Dimova; Teresa Mattina; Katrina Prescott; Hui Z Zhang; Howard M Saal; Jayne Y Hehir-Kwa; Marjolein H Willemsen; Charlotte W Ockeloen; Marjolijn C Jongmans; Nathalie Van der Aa; Pinella Failla; Concetta Barone; Emanuela Avola; Alice S Brooks; Sarina G Kant; Erica H Gerkes; Helen V Firth; Katrin Õunap; Lynne M Bird; Diane Masser-Frye; Jennifer R Friedman; Modupe A Sokunbi; Abhijit Dixit; Miranda Splitt; Mary K Kukolich; Julie McGaughran; Bradley P Coe; Jesús Flórez; Nael Nadif Kasri; Han G Brunner; Elizabeth M Thompson; Jozef Gecz; Corrado Romano; Evan E Eichler; Bert B A de Vries
Journal:  Eur J Hum Genet       Date:  2015-08-26       Impact factor: 4.246

2.  Genomic characteristics of miscarriage copy number variants.

Authors:  Hani Bagheri; Eloi Mercier; Ying Qiao; Mary D Stephenson; Evica Rajcan-Separovic
Journal:  Mol Hum Reprod       Date:  2015-06-12       Impact factor: 4.025

Review 3.  Chromosomal Microarrays: Understanding Genetics of Neurodevelopmental Disorders and Congenital Anomalies.

Authors:  Jill A Rosenfeld; Ankita Patel
Journal:  J Pediatr Genet       Date:  2016-05-30

4.  A higher mutational burden in females supports a "female protective model" in neurodevelopmental disorders.

Authors:  Sébastien Jacquemont; Bradley P Coe; Micha Hersch; Michael H Duyzend; Niklas Krumm; Sven Bergmann; Jacques S Beckmann; Jill A Rosenfeld; Evan E Eichler
Journal:  Am J Hum Genet       Date:  2014-02-27       Impact factor: 11.025

5.  Genome sequencing identifies major causes of severe intellectual disability.

Authors:  Christian Gilissen; Jayne Y Hehir-Kwa; Djie Tjwan Thung; Maartje van de Vorst; Bregje W M van Bon; Marjolein H Willemsen; Michael Kwint; Irene M Janssen; Alexander Hoischen; Annette Schenck; Richard Leach; Robert Klein; Rick Tearle; Tan Bo; Rolph Pfundt; Helger G Yntema; Bert B A de Vries; Tjitske Kleefstra; Han G Brunner; Lisenka E L M Vissers; Joris A Veltman
Journal:  Nature       Date:  2014-06-04       Impact factor: 49.962

6.  Deletions of chromosomal regulatory boundaries are associated with congenital disease.

Authors:  Jonas Ibn-Salem; Sebastian Köhler; Michael I Love; Ho-Ryun Chung; Ni Huang; Matthew E Hurles; Melissa Haendel; Nicole L Washington; Damian Smedley; Christopher J Mungall; Suzanna E Lewis; Claus-Eric Ott; Sebastian Bauer; Paul N Schofield; Stefan Mundlos; Malte Spielmann; Peter N Robinson
Journal:  Genome Biol       Date:  2014-09-04       Impact factor: 13.583

7.  Split Hand/Foot Malformation Associated with 7q21.3 Microdeletion: A Case Report.

Authors:  Aswini Sivasankaran; Ambika Srikanth; Pooja S Kulshreshtha; Deenadayalu Anuradha; Jayarama S Kadandale; Chandra R Samuel
Journal:  Mol Syndromol       Date:  2016-02-03

8.  Schizophrenia and the neurodevelopmental continuum:evidence from genomics.

Authors:  Michael J Owen; Michael C O'Donovan
Journal:  World Psychiatry       Date:  2017-10       Impact factor: 49.548

9.  TRIO loss of function is associated with mild intellectual disability and affects dendritic branching and synapse function.

Authors:  Wei Ba; Yan Yan; Margot R F Reijnders; Janneke H M Schuurs-Hoeijmakers; Ilse Feenstra; Ernie M H F Bongers; Daniëlle G M Bosch; Nicole De Leeuw; Rolph Pfundt; Christian Gilissen; Petra F De Vries; Joris A Veltman; Alexander Hoischen; Heather C Mefford; Evan E Eichler; Lisenka E L M Vissers; Nael Nadif Kasri; Bert B A De Vries
Journal:  Hum Mol Genet       Date:  2015-12-31       Impact factor: 6.150

10.  CAGI4 SickKids clinical genomes challenge: A pipeline for identifying pathogenic variants.

Authors:  Lipika R Pal; Kunal Kundu; Yizhou Yin; John Moult
Journal:  Hum Mutat       Date:  2017-06-27       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.